metadelfene
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Jul 1, 2009 (NCT00938379)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 3 Sponsor(trial)
Indications
Mechanism of action
- Serotonin 2b (5-HT2b) receptorANTAGONIST
HTR2B antagonist
Chemistry & pharmacology
Loading structure…
SMILES
CCN(CC)C(=O)c1cccc(C)c1- Mol. weight
- 191.27 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1453317 ↗
Also known as
- deet
- deet
- deet
- deet
- deet
- deet
- dieltamid
- diethyltoluamide
- diethyltoluamide
- diethyltoluamide
- diethyltoluamide
- diethyltoluamide
- metadelfene
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00938379 | Phase 3 | Jul 1, 2009 | Population Services International, University of London |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Population Services International | Academic/Hospital | 1 | 0 | 1 | 2009 |
| University of London | Academic/Hospital | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1